{"id":"W1580153842","doi":"10.1158/1538-7445.am2014-666","title":"Abstract 666: AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alethia Biotherapeutics (Canada)","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer; LNCaP; Prostate cancer; Antibody; Monoclonal antibody; Medicine; Serous fluid; Antigen; Triple-negative breast cancer; Cytotoxic T cell; Breast cancer; Internal medicine; Chemistry; Immunology; In vitro","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001603361,0.0004871476,0.0003616156,0.0003796561,0.0001898081,0.000256507,0.0002925681,0.0003730925,0.001837722],"category_scores_gemma":[0.00007054684,0.0001548564,0.0003201169,0.0002358883,0.0002024355,0.0002191888,0.0001216184,0.0007788319,0.0006273429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004163581,"about_ca_system_score_gemma":0.0002907718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007815798,"about_ca_topic_score_gemma":0.0006163585,"domain_scores_codex":[0.9998378,0.00002330262,0.00001275797,0.00003330976,0.00004987266,0.00004305862],"domain_scores_gemma":[0.9999216,0.000008177485,0.00001949839,0.000008193941,0.00001498502,0.00002745128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002693454,0.0001505221,0.00006246021,0.0000264723,0.000007846465,0.00003144665,0.000006011619,0.00008592638,0.9984428,0.00005309505,0.0000678804,0.0007961278],"study_design_scores_gemma":[0.00003321426,0.0009808686,0.0008155101,0.000002161396,0.00001457683,0.0001344971,0.000006143418,0.000573768,0.9961019,0.00001553644,0.001319255,0.000002534489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938322,0.001144721,0.00213802,0.0001523118,0.00008712656,0.00008678382,0.0006376854,0.0001631619,0.001757905],"genre_scores_gemma":[0.9884015,0.0005979058,0.002399936,0.0000650177,0.00002063445,0.00007526011,0.00135386,0.00003581217,0.00705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001837722,"threshold_uncertainty_score":0.006147802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05511131120432988,"score_gpt":0.390798829242364,"score_spread":0.3356875180380341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}